483 Alkermes Apr 2005

483 Alkermes Apr 2005

Mark Parmon FDA, Roy Stephens FDA$595.00 - Available Now

FDA investigators audited the Alkermes - Wilmington, OH, United States facility and issued inspectional observations (via FDA 483) on 15 Apr 2005.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Apr 2005
  • Location: Wilmington, United States
  • FEI: 1000142940
Add To Cart